# FDA Inspection 1017164 - Charu Aggarwal, MD, MPH, Hematology-Oncology Division - March 28, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/charu-aggarwal-md-mph-hematology-oncology-division/47299dc4-c9e5-426e-b63d-33cf9ceec5b8
Source feed: FDA_Inspections

> FDA Inspection 1017164 for Charu Aggarwal, MD, MPH, Hematology-Oncology Division on March 28, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017164
- Company Name: Charu Aggarwal, MD, MPH, Hematology-Oncology Division
- Inspection Date: 2017-03-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.globalkeysolutions.net/companies/charu-aggarwal-md-mph-hematology-oncology-division/8e6529bd-6bbe-400c-a06b-816a5ff26a98

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c